Back to funds
View filing
Sofinnova Investments, Inc.
hedge fundUpdated 27 days agoManaged by Sofinnova Investments, Inc. • Latest filing Q2 2026
Portfolio value
$1.9B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
96.8%
Weight of largest holdings
Annualized return
2.8%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.6B |
| Q2 2023 | $1.5B |
| Q3 2023 | $1.6B |
| Q4 2023 | $1.8B |
| Q1 2024 | $1.8B |
| Q2 2024 | $1.9B |
| Q3 2024 | $1.3B |
| Q4 2024 | $1.4B |
| Q1 2025 | $1.5B |
| Q2 2025 | $1.6B |
| Q3 2025 | $1.8B |
| Q4 2025 | $2.3B |
| Q1 2026 | $2.6B |
| Q2 2026 | $1.9B |
Top holdings
57 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | N NTRA Natera Inc | $420.8M | 1.55M | 21.76% | — |
| 2 | V VERA Vera Therapeutics Inc | $119.9M | 2.79M | 6.20% | — |
| 3 | G GNMSF Genmab A/S | $111.1M | 4.05M | 5.74% | — |
| 4 | J JAZZ Jazz Pharmaceuticals PLC | $88M | 365.3K | 4.55% | — |
| 5 | R RAPP Rapport Therapeutics Inc | $79.4M | 1.90M | 4.10% | — |
| 6 | ? N/A Seaport Therapeutics Inc | $77.4M | 3.56M | 4.00% | — |
| 7 | ? N/A Arrivent BioPharma Inc | $58.9M | 1.70M | 3.05% | — |
| 8 | R RARE Ultragenyx Pharmaceutical In | $57.3M | 1.72M | 2.96% | — |
| 9 | ? N/A BioAge Labs Inc | $56.2M | 2.29M | 2.91% | — |
| 10 | C CELG-RI Bristol-Myers Squibb Co | $50.5M | 877.0K | 2.61% | — |
| 11 | S SUPN Supernus Pharmaceuticals | $48.2M | 1.04M | 2.49% | — |
| 12 | R RYTM Rhythm Pharmaceuticals Inc | $45.3M | 408.0K | 2.34% | — |
| 13 | G GILD Gilead Sciences Inc | $43.3M | 343.1K | 2.24% | — |
| 14 | U UTHR United Therapeutics Corp Del | $41.4M | 76.5K | 2.14% | — |
| 15 | C COGT Cogent Biosciences Inc | $40.1M | 1.04M | 2.07% | — |
| 16 | A AXSM Axsome Therapeutics Inc. | $39.3M | 160.4K | 2.03% | — |
| 17 | I IMTX Immatics N.V | $37.2M | 3.67M | 1.92% | — |
| 18 | D DYN Dyne Therapeutics Inc | $36.8M | 1.66M | 1.90% | — |
| 19 | I IMNM Immunome Inc | $36.5M | 1.72M | 1.88% | — |
| 20 | I IDYA IDEAYA Biosciences Inc | $34.5M | 925.1K | 1.78% | — |